Sepracor

Acquired

Innovative Treatments, Science and Technology

Marlborough, United States · Founded 1984 · $10.5M raised

Employees
501–1000
Founded
1984
Business Model
B2B
Total Funding
$10.5M
Last Round
$10.0M Venture RoundJun 1993
Rounds
2
Acquisition Date
Oct 2009

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Bioactive membranes and other separation technologies for the chemical processing and pharmaceutical fields

Summary

Sepracor is a Drug Discovery company based in Marlborough, United States, founded in 1984. It has raised $10.5M in total across 2 rounds, most recently a $10.0M Venture Round in Jun 1993. Investors include Dainippon Sumitomo Pharma, Marion Merrell Dow and Lehman Brothers.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

AcquisitionOct 2009

Sign up to see all 4 events

Funding: Seed through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
ArsenalBio

Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

San Francisco, United States201–500Biotech, Life Sciences
Series CTotal funding$955.0MSep 2024
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sepracor on Indexed.vc
<a href="https://indexed.vc/companies/sepracor"><img src="https://indexed.vc/api/badge/company/sepracor" alt="Sepracor on Indexed.vc" width="260" height="76" /></a>